This inventor holds 50 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Cellulolytic Enzymes. Top assignees: Novozymes, Inc., Novozymes A/s, Novo Nordisk A/s. Active years: 1997-2025.
Location History:
- Woodland, CA (US) (1997 - 2009)
- Davis, CA (US) (2003 - 2022)
Company Filing History:
28 out of 384 
11 out of 1,417 
8 out of 1,799 
Years Active: 1997-2025
Areas of Expertise:
Title: The Innovations of Feng Xu: Pioneering Advances in Bioprocessing
Introduction: Feng Xu, an accomplished inventor based in Davis, California, has made significant contributions to the field of biotechnology, particularly through his extensive work on enzyme applications in fermentation processes. With a remarkable portfolio of 49 patents, he has established himself as a leading figure in bioprocess innovation.
Latest Patents: Among his notable inventions are methods aimed at enhancing the efficiency of starch to ethanol processes. One of his latest patents, titled "Method of Dewatering Post Fermentation Fluids," introduces a novel approach to dewatering whole stillage using nuclease enzymes. This inventive process not only separates the stillage into an insoluble fraction and a supernatant fraction but also optimizes the overall yield of ethanol production. Another significant patent is focused on compositions comprising a polypeptide with cellulolytic enhancing activity, offering new possibilities in liquors and their applications. These contributions underscore his commitment to advancing biotechnology and sustainable processes.
Career Highlights: Feng Xu's career includes pivotal roles at prominent companies like Novozymes, Inc. and Novozymes A/S, where he honed his expertise in enzyme development and application. His innovative spirit has driven numerous projects that have a lasting impact on the industry, shifting paradigms in biotechnological approaches to production efficiency.
Collaborations: Throughout his career, Feng has collaborated with knowledgeable experts, including Jason Quinlan and Matthew David Sweeney. These collaborations have fostered a creative atmosphere that promotes the development of cutting-edge technologies in enzymatic processes and bioproducts.
Conclusion: Feng Xu's contributions to the biotechnology sector through his inventions and collaborative efforts signify a formidable impact on the industry. His continued work is expected to play a crucial role in the future of sustainable production processes, positioning him as a key innovator in the domain of enzymatic applications and bioprocessing.